News & Updates

Medication risks an acceptable trade-off for cure of IBS symptoms
Medication risks an acceptable trade-off for cure of IBS symptoms
07 Mar 2022

Patients with irritable bowel syndrome (IBS) are willing to take on significant medication risks in exchange for a permanent cure of their symptoms, a study has found.

Medication risks an acceptable trade-off for cure of IBS symptoms
07 Mar 2022
Traditional dietary advice most preferred for IBS
Traditional dietary advice most preferred for IBS
07 Mar 2022
Universal HCV screening in pregnancy: A step toward reducing transmission?
Universal HCV screening in pregnancy: A step toward reducing transmission?
01 Mar 2022 byRoshini Claire Anthony

Universal screening for hepatitis C virus (HCV) in pregnant individuals resulted in improved detection and a potential reduction in perinatal transmission, according to a study presented at CROI 2022.

Universal HCV screening in pregnancy: A step toward reducing transmission?
01 Mar 2022
Allopurinol use, dose escalation do not increase mortality in gout patients with CKD
Allopurinol use, dose escalation do not increase mortality in gout patients with CKD
01 Mar 2022

In patients with gout and concurrent chronic kidney disease (CKD), the risk of mortality does not seem to increase with initiation of allopurinol, achieving target serum urate (SU) level with allopurinol, or treatment dose escalation, a study has shown.

Allopurinol use, dose escalation do not increase mortality in gout patients with CKD
01 Mar 2022